PMDA drug package insert
フルチカゾンフランカルボン酸エステル点鼻液27.5µg「杏林」56噴霧用
PMDA Prescription drug · キョーリンリメディオ株式会社 · package insert May 27, 2024
Key facts
| Brand names | フルチカゾンフランカルボン酸エステル点鼻液27.5µg「杏林」56噴霧用, フルチカゾンフランカルボン酸エステル点鼻液27.5µg「杏林」120噴霧用 |
|---|---|
| Nonproprietary names | フルチカゾンフランカルボン酸エステル |
| Companies | 製造販売元／キョーリンリメディオ株式会社, 販売元／杏林製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 定量噴霧式アレルギー性鼻炎治療剤 |
| Therapeutic category codes | 871329 |
| YJ codes | 1329711Q3024, 1329711Q4020 |
| Approval numbers | 30500AMX00085000, 30500AMX00086000 |
| Package insert edition | 第2版 |
| Package insert date | May 27, 2024 |
| PMDA document key | 480209_1329711Q3024_1 |
| PMDA company code | 480209 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: